glp-1 receptor agonist transdermal patch A Closer Look at the Dermatological Profile of Agonists glp-1 receptor agonist transdermal patch

Beyond the nervous system, liraglutide intervention alleviates doxorubicin-induced testicular damage and cognitive dysfunction by counteracting oxidative injury and restoring PI3K/Akt/mTOR signaling homeostasis

Carlessi, R., Chen, Y., Rowlands, J., Cruzat, V

With anticipation of aleniglipron being a strong contender in the still-emergent GLP-1 pill space, investors who take a chance on GPCR shares may be rewarded with a bump when new results do become available, although this is, of course, a risk

In the STEP UP clinical trial, the 7.2 mg dose produced a mean weight loss of 20.7% at 72 weeks, compared with 17.5% at the previously approved 2.4 mg dose and 2.4% with placebo

Ethics declarations Competing interests E.M

But more research is needed in humans